tailieunhanh - Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

Pazopanib is indicated in the first-line treatment of metastatic renal cell cancer (mRCC). The aim of this study was to review the efficacy, safety, and pharmacokinetics of pazopanib and see how these aspects are linked to clinical practice. | Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma

TỪ KHÓA LIÊN QUAN